New hope for pancreatic cancer: triple therapy targets tumors from multiple angles
NCT ID NCT06492915
First seen Mar 18, 2026 · Last updated May 05, 2026 · Updated 4 times
Summary
This study tests a new drug called chiauranib combined with two standard chemotherapies as a first treatment for people with advanced pancreatic cancer that cannot be removed by surgery. The drug works by blocking several key processes that help tumors grow and spread. The trial includes 42 participants and aims to see if the combination helps control the disease longer than standard care alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.